MS Public Seminar: MARIA BENAVENTE
When & Where
May 16
1:30 PM - 2:30 PM
UTH Health, McGovern Medical School, MSB 3.301 and via Microsoft Teams (View in Google Map)
Contact
- Joy Lademora
- 7135009872
- [email protected]
Event Description
Use of the Protein Misfolding Cyclic Amplification for Food Safety and Drug Discovery
Maria Rebecca Benavente Garcia-Huidobro (Advisor: Rodrigo Morales, PhD)
Prion diseases are fatal neurodegenerative disorders caused by the misfolding of the normal prion protein (PrPC) into its infectious form (PrPSc). While the zoonotic potential of chronic wasting disease (CWD) remains uncertain, the presence of prions in food products raises public health concerns. Additionally, therapeutic strategies for prion diseases remain limited. This thesis presents a methodological exploration of the Protein Misfolding Cyclic Amplification (PMCA) technique to address these challenges in two key areas: (1) detecting CWD prions in processed meats subjected to common cooking procedures, and (2) identifying potential anti-prion compounds through a high-throughput PMCA adaptation.
Our results demonstrate that PMCA effectively detected CWD prions in a range of processed meat products, with an unexpected increase in prion detectability following grilling and boiling, suggesting enhanced prion accessibility post-cooking. Despite this, these prions failed to convert the human prion protein in PMCA reactions, indicating a limited zoonotic risk under the conditions/materials tested.
In parallel, a modified 96-well plate PMCA screening strategy identified eight promising compounds with inhibitory effects on PrPSc formation. Notably, these candidates exhibited diverse properties, including both hydrophilic and hydrophobic profiles, with some compounds previously linked to amyloidogenic pathway inhibition.
This study highlights the versatility of the PMCA technique for both, food safety assessments and screening anti-prion compounds. The results presented in this thesis work stress the importance of exploring prion strain diversity, refining PMCA protocols, and validating potential inhibitors in in vivo models for future therapeutic development.
Advisory Committee:
- Rodrigo Morales, PhD, Chair
- Tatiana Barichello, PhD
- Kartik Venkatachalam, PhD
- Seung-Hee Yoo, PhD
- Sheng Zhang, PhD
Join via Microsoft Teams (Please contact Ms. Maria Benavente for her Microsoft Teams meeting info.)
Use of the Protein Misfolding Cyclic Amplification for Food Safety and Drug Discovery
Maria Rebecca Benavente Garcia-Huidobro (Advisor: Rodrigo Morales, PhD)
Prion diseases are fatal neurodegenerative disorders caused by the misfolding of the normal prion protein (PrPC) into its infectious form (PrPSc). While the zoonotic potential of chronic wasting disease (CWD) remains uncertain, the presence of prions in food products raises public health concerns. Additionally, therapeutic strategies for prion diseases remain limited. This thesis presents a methodological exploration of the Protein Misfolding Cyclic Amplification (PMCA) technique to address these challenges in two key areas: (1) detecting CWD prions in processed meats subjected to common cooking procedures, and (2) identifying potential anti-prion compounds through a high-throughput PMCA adaptation.
Our results demonstrate that PMCA effectively detected CWD prions in a range of processed meat products, with an unexpected increase in prion detectability following grilling and boiling, suggesting enhanced prion accessibility post-cooking. Despite this, these prions failed to convert the human prion protein in PMCA reactions, indicating a limited zoonotic risk under the conditions/materials tested.
In parallel, a modified 96-well plate PMCA screening strategy identified eight promising compounds with inhibitory effects on PrPSc formation. Notably, these candidates exhibited diverse properties, including both hydrophilic and hydrophobic profiles, with some compounds previously linked to amyloidogenic pathway inhibition.
This study highlights the versatility of the PMCA technique for both, food safety assessments and screening anti-prion compounds. The results presented in this thesis work stress the importance of exploring prion strain diversity, refining PMCA protocols, and validating potential inhibitors in in vivo models for future therapeutic development.
Advisory Committee:
- Rodrigo Morales, PhD, Chair
- Tatiana Barichello, PhD
- Kartik Venkatachalam, PhD
- Seung-Hee Yoo, PhD
- Sheng Zhang, PhD
Join via Microsoft Teams (Please contact Ms. Maria Benavente for her Microsoft Teams meeting info.)
", "startDate":"2025-5-16", "endDate":"2025-5-16", "startTime":"13:30", "endTime":"14:30", "location":"UTH Health, McGovern Medical School, MSB 3.301 and via Microsoft Teams", "label":"Add to Calendar", "options":[ "Apple", "Google", "iCal", "Microsoft365", "MicrosoftTeams", "Yahoo" ], "timeZone":"America/Chicago", "trigger":"click", "inline":true, "listStyle":"modal", "iCalFileName":"Reminder-Event" }